ArticleClinical optometry2026
A Pilot Study of Retinal Vessel Calibre and Its Potential Link to Cardiovascular Risk in HIV.
Article in Clinical optometry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This pilot study investigates the effects of HIV and antiretroviral therapy (ART) on retinal vessel calibre in immunocompetent people living with HIV (PLHIV). Changes in vessel calibre in HIV-positive individuals may serve as biomarkers of iBRB integrity and endothelial dysfunction. Methods: This was a cross-sectional study. Fundus photography was conducted in three groups: HIV-positive individuals on ART (HIV-ART, n=62 eyes), HIV-positive ART-naïve individuals (HIV-NART, n=20 eyes), and a comparison group of HIV-negative controls (n=82 eyes). We evaluated retinal vessel calibres (Arteriolar widths, venular widths, central retinal artery equivalent (CRAE), central retinal vein equivalent (CRVE), arteriole-venule ratio (AVR) using VAMPIRE software. Association models included Multivariable regression, generalized estimated equations, and mixed effects models. Results: The mean venular width was significantly greater among PLHIV compared to HIV-negative controls (p=0.003). Longer ART duration was associated with the narrowing of venules in the HIV-ART group, particularly affecting mean venular width (β=-1.40 μm, p=0.02) and CRVE (β=-4.44 μm, p=0.05). The generalized model showed longer ART duration was positively associated with wider arteriolar calibre (β=7.09 μm for CRAE, p=0.001). The HIV-NART group had a significantly higher odds of abnormal CRAE (OR=3.00; p=0.033) compared to controls. Conclusion: This study provides a novel perspective on the probable link between retinal vessel calibre and systemic HIV factors, suggesting a possible relationship to systemic vascular health. All health clinicians should be aware of the potential for ART to influence retinal microvasculature. Future research should focus on larger cohorts and longitudinal studies to track changes in vessel calibre over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.